GFI1 and cancer: We explored the underlying mechanism by which GFI1 regulates the transcriptional program, promoting detachment, anoikis resistance, and metastasis, and we evaluated its clinical implications in predicting sensitivity to ERK signaling inhibitors in cancer treatment.